Daiichi Sankyo Company, Limited (DSKYF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
At close: 01:58PM EDT
| Previous close | 35.03 |
| Open | 35.90 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 34.63 - 36.00 |
| 52-week range | 23.45 - 37.91 |
| Volume | |
| Avg. volume | 23,498 |
| Market cap | 68.302B |
| Beta (5Y monthly) | 0.26 |
| PE ratio (TTM) | 53.16 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 0.39 (1.09%) |
| Ex-dividend date | 27 Sept 2024 |
| 1y target est | N/A |
- Yahoo Finance
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
- Zacks
Atossa (ATOS) Reports Positive Results From EVANGELINE Study
Atossa (ATOS) unveils positive results from its phase 2 EVANGELINE clinical study, which shows that (Z)-endoxifen can reduce the growth of ER+ breast cancer.
- Zacks
Merck (MRK) Begins Phase II/II Ovarian Cancer Study on ADC Drug (Revised)
Merck's (MRK) phase II/III study called REJOICE-Ovarian01 study will evaluate the efficacy of raludotatug deruxtecan in patients with platinum-resistant ovarian cancer.
© 2024 Yahoo. All rights reserved.